The Alcoholics Anonymous (AA) movement created the term "in recovery" to express the continuing requirement for vigilance in order to sustain sobriety (which includes abstinence from alcohol intake) and avoid a return to dangerous drinking. This term, or identity, may be adopted by someone who considers themselves to be in recovery for the rest of their lives. Recovery is considered to entail gains in health and wellbeing, and has been described as a social process in which individuals learn to absorb new norms and values as part of a recovery-oriented identity, but it is not specifically...

The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and medication for OUD are considered the top standard of care in substance use disorder (SUD) treatment, many people with OUD receive just counseling or methadone-only therapies. This study compares gender inequalities in methadone-based treatment plan progress to counseling-based programs in one of the biggest SUD treatment systems in the United States.

The...

In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of opioid use disorder (OUD). The objective of this study is to investigate the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.

Data were manually extracted from electronic health records for all ED patients with OUD treated with buprenorphine at a single, urban, safety-net hospital in Oakland...

2021 INCSR–Volume I: Drug and Chemical Control (As submitted to Congress)

To read the full report, please visit: https://www.state.gov/2021-incsr-volume-i-drug-and-chemical-control-as-submitted-to-congress/

The Global Synthetic Drugs Assessment 2020 provides an analysis of the global synthetic drugs market.

• The first part of this report provides options for responses to counter the synthetic drug problem.
• The second part presents a global thematic analysis of the key trends and emerging developments of the synthetic drugs market as well as the recent trends in the manufacture of synthetic drugs, including the effects of the COVID-19 pandemic.
• The third part provides the key findings of the synthetic drug situation in the different regions of the world.

Global Synthetic Drugs Assessment

The University of California San Diego, School of Medicine, Department of Psychiatry, is honored to award you with a full tuition scholarship to the virtual 49th Summer Clinical Institute in Addictions Studies 2020.

You will have a chance to interact and learn from the world leading experts , scientists, practitioners and policy makers in the area of Substance Use Disorders. We would like to thank the Scaife Family Foundation for their continues support of the institute, particularly scholarships for students and trainees.

The Institute will be held on June 2 & 3.

Please visit the...

The goal of treatment for opioid addiction or opioid use disorder (OUD) is remission of the disorder leading to lasting recovery.

Recovery is a process of change through which individuals improve their health and wellness, live self-directed lives, and strive to reach their full potential. 

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.